Nanobodies (Nbs) are single domain antibodies derived from camelids. The facile identification of antigen-specific Nbs and their beneficial biochemical and economic properties (size, affinity, specificity, stability, production cost) supported by multiple crystal structures have encouraged antibody engineering of these single-domain antibodies for use as research tools and in biotechnology and medicine.
In recent years, we have witnessed the increasing impact of Nanobodies in diverse disciplines. However the lack of a comprehensive nanobody database is hampering open science and reproducible research. Inspired by the success and the global impact of the Protein DataBase (PDB), a small International task force took the initiative to establish the Nanobody DataBase (NanoDB.org).
As an open access database, NanoDB aims to promote the widespread use of well characterized Nanobodies by the entire research community. NDB will be a quality curated database that provides unique identifiers linked to the amino acid sequence of the entire Nanobody.
We aim to convince the leading journals to require submission of all Nanobody sequences to the NanoDB, before papers can be accepted for publication that report the derivation and/or use of Nanobodies.
We need your support
To make this effort a success, we need the commitment of the entire Nanobody community to this initiative and willingness to deposit their relevant Nanobody sequences to NanoDB.
In order to secure funding for the NanoDB, and to strengthen our case towards journal editorial boards, we are currently setting up a support group of prominent scientists that embrace this initiative. Therefore we ask you to sign this commitment statement.
Nanobody is a registered trademark of Ablynx